HIF1A and renal carcinoma: A large body of research has identified HIF1A-AS2 as a tumor-related lncRNA and acts as a tumor promoter, as demonstrated by in vitro and in vivo experiments, such as in gastric cancer (GC), breast cancer (BC), bladder cancer, osteosarcoma (OS) and renal cancer (RC) (12–16).